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Diabetes is a growing healthcare problem in the world, which affects over 400 mil-
lion adults. In collaboration with Haukeland University Hospital, we look at medical
records from real patients diagnosed with diabetes. The study uses machine learning
to predict if a given patient has a high risk of experiencing medical deterioration.
Further, the thesis goes through the data cleaning necessary to provide such pre-
dictions. The first approach managed to identify 79% of high-risk patients. If the
model classifies a patient to have a high risk of mortality, the model had an accuracy
of 18%. In the second approach, we removed the last four weeks before mortality
happens, and the model was able to identify 49% of the patients with high risk. If
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1 Introduction
In 2016, there were 206 795 registered medical patients with Diabetes in Norway,
and there were 481 amputations where diabetes was the main contributor[2]. World
Health Organization(WHO) published a report[24], which stated that the number
of adults with diabetes was 422 million in 2016. Furthermore, WHO noted that the
number of deaths directly connected to diabetes was 1.5 million in 2012. If deaths
related to high blood glucose levels are included, the number of deaths goes up by
another 2.2 million people.
Patients with diabetes are expected to manage their decease in multiple ways.
The patients need to track exercise, diet, low blood sugar episodes, insulin adminis-
tration, and foot care. By detecting patients with a high risk of medical deterioration
early, the Health Care Service can reach out to these patients and offer assistance.
Offering assistance could lead to a decrease in the number of patients that experience
medical deterioration, an increase in the quality of life for patients, and reduces the
number of cases where diabetes leads to disability. Fewer required medical interven-
tions will save the health care system resources. At the same time, the government
will save money since they don’t have to pay disability payments. As the number
of patients with diabetes is too high for doctors to go through medical records to
see if a patient is at the risk of experiencing medical deterioration, this project was
completed to see if that process could be automated using machine learning.
A survey from 2012 made by Ponemon Institute found that 30% of all stored
data belongs to the healthcare industry.[14] In November 2018, IDC predicted that
the world contains 33 zettabytes of data, and it is not slowing down. Further, they
predict that in 2025, it will contain 175 zettabytes. [27]. Data itself is not useful, as
Ziad Obermeyer and Ezekiel J. Emanuel said: "To be useful, data must be analyzed,
interpreted, and acted on." [20] One of the solution is Machine Learning(ML). While
a Doctor, with years of training, may be able to look at 200 MR-scannings a day
and predict whether or not a brain has a tumor. You can do the same with machine
learning, but both training and prediction will take much less time. Machine learning
may also be able to predict with better accuracy than doctors. In May 2019, a
study[5] compared eight radiologists to a Google algorithm in making predictions
on lung cancer screenings. The algorithm beat all radiologists and had an 11%
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reduction in false positives, which is the main problem in lung cancer screening
predictions, and was able to detect 5% more cancerous human beings than the
radiologists.
In collaboration with Haukeland University Hospital, hence referenced Hauke-
land, we look at medical records for 20.000 patients diagnosed with diabetes. The
data contains events from real patients at Haukeland, although some personal data
is hashed to prevent it from being easily identifiable. The data required a lot of
analysis and cleaning for a machine learning model to be able to make predictions
regarding a patient’s risk of experiencing medical deterioration.
1.1 Research questions
• How well can medical record data be used in machine learning to
predict medical deterioration of patients diagnosed with diabetes?
As mentioned above, a lot of personal factors and lifestyle choices affect dia-
betes. The data provided by Haukeland is purely medical record data, which
lacks information about a patient’s lifestyle and personal events.
• By removing the latest events for a patient, how early can the risk
of medical deterioration by identified?
Predicting that a patient will need an amputation or die today, gives no value
as the healthcare system does not have time to react. For the thesis solution
to be of value, it needs to be able to identify high-risk patients as early as
possible.
1.2 Thesis Structure
The thesis starts with an overview of the problem description, before giving an in-
depth explanation of what diabetes is and its consequences to society. Then the
thesis goes through machine learning and techniques used to achieve our findings,
which will be beneficial when reading the rest of the report. After the introductory
chapters, the report goes through the thesis’ research approach, which explains all
steps taken in the research, followed by ethics in medical research. Further, an
explanation of the structure and processing of the data is given. The next chapters
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are about the experiments completed in the thesis, followed by an interpretation of




This chapter gives a more in-depth explanation of diabetes and how its consequences
affect society.
2.1 What is diabetes?
Diabetes is a chronic health condition that causes the body’s insulin levels to be
too low or that the body is resistant to insulin. Insulin is used to transfer sugar or
glucose from the body’s blood and into cells and muscles. If the glucose stays in
the blood, it leads to too high glucose levels in the blood. If a person has too high
glucose levels over time, it can lead to several health problems, such as eye diseases,
heart diseases, or amputation[22]. There exist several medications to reduce blood
glucose levels, such as insulin. It exists mainly three different types of diabetes:
Type 1 Diabetes
The body’s immune system mistakes healthy cells for unhealthy ones, and attacks
and destroys insulin-producing beta cells[25]. As the body destroys the cells, it
leads to the body having problems producing insulin on its own. Why the body
attacks these cells is not known, but researchers are working on finding out why.
For example, TrialNet is a company dedicated to research and prevent diabetes type
1.
Type 2 Diabetes
People with diabetes type 2 have resistance to insulin; the body is still producing
it, but can’t use it efficiently. As the body has a problem using insulin, the body
increases insulin production. Over time, the body can’t produce enough insulin, and
an increase in glucose in the bloodstream happens[23]. Furthermore, other contrib-




Gestational diabetes is a type of diabetes women can get under pregnancy., caused
by hormone changes in the body during pregnancy, lifestyle, and genes.
A common contributor which increases the risk of developing diabetes is genes.
Genes affect type 2 and gestational diabetes more than type 1. Although, American
Diabetes Association states that genes alone are not enough to develop diabetes[6].
Genetic mutations, diseases, damage to the pancreas, and medications can also cause
diabetes[23].
2.2 Cost of diabetes
One study[31] estimated that in 2011, the total cost of diabetes was 516 million
euros in Norway. The total cost of diabetes, 78 million euros, was connected to the
"cost of in-patient hospital care of the most common comorbidities in diabetes."
Furthermore, the indirect costs, which includes sick leave money, productivity loss,
disability pension, and basic benefit and attendance, consisting of 107.6 million euro.
By using costed numbers given by Haukeland, we can state that the mean costs for
DRG213 - amputation for musculoskeletal system and connective tissue disorders
is 167 869 Norwegian kroner(KR) for Haukeland. The mean cost for DRG113 -
amputation for circ system except upper limb and toe is 150 670 KR. These numbers
are provided by Siw Ottesen Iversen, Controller at Haukeland, and Anne-Mette Tang
- Controller at Haukeland, through personal communication in January 2020. By
reducing the cost of diabetes, the healthcare industry can increase budgets in other
areas and focus on other diseases. Also, by reducing the number of operations needed
for patients with diabetes, it can free up time for surgeons and other healthcare
personnel. Lastly, by helping patients avoid medical deterioration, it can reduce
suffering for individuals diagnosed with diabetes, which is a big reward in itself.
Increasing public health can further bring down the cost regarding sick leave money,
productivity loss, disability pension, and basic benefit and attendance.
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2.3 Managing and risk reduction for diabetes
Some patients with diabetes experience medical deterioration because they do not
follow the optimal/planned medication plan. Other reasons can be regarding the
patient’s lifestyle, such as lack of training or eating unhealthy. There are multiple
ways to reduce the risk of experiencing medical deterioration. National Institution
of Diabetes and Digestive and Kidney Diseases(NIDDK) have created an ABCs for
managing diabetes[21]. These are :
• A for the A1C test, which is a test that shows the average blood glucose level
over the last three months.
• B for blood pressure.
• C for cholesterol. There are two types of cholesterol, one "good" and one
"bad." Having a high level of bad cholesterol increases the risk of heart attack
or stroke.
• S for stop smoking. Both diabetes and smoking affect a person’s blood. Stop-
ping smoking can lower the risk of multiple diseases, improve cholesterol, blood
pressure, and blood circulation.
Furthermore. NIDDK also states that following a diabetes meal plan help managing
blood glucose, blood pressure, and cholesterol. Being more physically active, taking
medicines, and regularly checking blood glucose levels will also help to manage the
ABCs. Especially important for this project is that they also state that you should
work with your health care team. They state that a patient should meet with the
health care team at least once every two years or more often if a patient is having
trouble managing their diabetes. This statement also supports the assumption that
having consultation sessions can prevent medical deterioration.
The goal of the thesis is to be able to identify patients with a high risk of med-
ical deterioration before it is too late. The healthcare system can reach out to
patients and help them set up a medical plan to reduce future risk.
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3 Machine Learning
This chapter contains basic concepts of ML, which will be useful when reading the
rest of the thesis.
3.1 What is Machine Learning?
Machine learning is the science of programming a system/program that can learn
from data. Instead of programmers or other involved persons to create rules for a
system to follow, machine learning can detect patterns in the data by itself, which
can be used to set up conditions and learn something about the data. A post-trained
network should be able to make determinations or predictions about data the system
has not seen before. [10]
3.2 Types of machine learning
In machine learning, there exist three different types of machine learning, which is
supervised, unsupervised, and reinforcement learning. One of the first things we
had to do was to define which category our problem would fit in.
Supervised learning
In supervised learning, all your data is labeled. For example, if creating a model that
can predict if a patient has diabetes, the model would need data of patients with
and without diabetes. The training data contains the answer. Supervised learning
is used for classification/categorization or regression. An example of a supervised
learning study is "Deep learning algorithm predicts diabetic retinopathy progression
in individual patients"[4], where a neural network was created to predict diabetic
retinopathy for patients with diabetes. This study used images with binary labels.
Unsupervised learning
Not all data sets are labeled, and sometimes researchers may not know the specific
results they are seeking. In supervised learning, the model goes over the data to
discover patterns. It is used for clustering and dimensional reduction of the data.
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Reinforcement learning
In reinforcement learning, there exists an agent, which makes decisions in a created
environment. The agent usually has a goal, such as to find a way out of a labyrinth.
When the agent makes an action, it either receives a reward or a punishment. By
repeating this step, the agent learns to maximize the rewards and make its way out
of the labyrinth. This type of machine learning has been used in a lot of games,
for example, in Dota 2[11] or Chess[29]. Without domain knowledge, the agent can
learn the best moves in the games and achieve superhuman performance.
In our work, we use supervised learning since we marked the outcome of each pa-
tient, such as the severity of the outcome when an adverse event happens, such as
eye operation and amputation. We could have used unsupervised learning as well
to group patient; however, we decided to use supervised learning since we wanted to
use machine learning to predict the outcome. We did not consider reinforcement in
this work; however, in the discussion, we will discuss how reinforcement could have
been used to improve the behavior of diabetes patients.
3.3 Overfitting and underfitting
The goal is that our model will be able to generalize, which means to give accurate
predictions on a large quantity of data, instead of perfect predictions on a small
subset of a data set. A model may predict perfectly on training data, but when it
predicts on unseen data, it performs terribly. The model has not learned to generalize
but learned the exact patterns of the training data. When a model performs well
on training data, but not on unseen data, the model has overfitted. An overfitted
model usually has a high error when predicting on validation data. Overfitting can
be seen in the last graph below.
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Figure 1: Bias variance tradeoff graph
Underfitting is when a model is unable to detect the patterns in the data, which
means the model is not able to give precise predictions on any data. Underfitting
usually has a high loss on both training and validation data. The first graph above
shows underfitting.
In our model, we want something in between. A model that performs well on
both training and the test data. This can be measured by low loss in both training
and validation.
3.4 Feature Engineering
Before we could use the data from Haukeland hospital, we needed to do future
engineering on it; make the data in a structure that is readable by the machine
learning network. In addition, future engineering helps increase the performance of
our model. Future modeling is done by removing or altering the data. These steps
were a large part of the thesis, and the specific actions will be described in section
7.2. This step is where raw data is transformed into a new dataset, which is easier
to interpret for a machine learning model. Feature engineering can be split into two
different parts, called feature selection and feature extraction.
• Feature selection: The process of selecting features in the dataset to use during
both training and predictions. The goal is to select features that contribute
the most to the prediction of the data. Using bad features can negatively
affect your model’s precision as the model learns on irrelevant data. Feature
engineering can give benefits such as increased accuracy, reduced overfitting,
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and reduced training time.
• Feature Extraction: The process of creating new features based on existing
features. The goal is that the new features are in a lower dimension than
the original features, and still preserve data important for prediction. Known
techniques to Feature extraction is principal component analysis(PCA), linear
discriminant analysis(LDA), and more.
3.5 bias-variance trade off
In machine learning, a goal is to minimize both bias and variance, but lowering one
usually increases the other. Bias in machine learning is the average between the
predicted values and true values. Models that are too simple for the data have high
bias and usually underfits.
When a model has high variance, it has "learned" all the noise in the data, and
will predict well on the training data, but perform worse on the test data. The
model will overfit. It would be unfortunate if we created a model that was able to
identify all patients who had an amputation in our data, but when exposed to a new
dataset, it was not able to identify anyone. If we can find the right balance between
bias and variance, the model can avoid both overfitting and underfitting.
3.6 Cross validation
20.000 patients may sound like a large amount; however, few patients experienced
medical deterioration. We need data for training, validation, and testing. To not
further decrease the number of negative outcomes when training the model, we need
to split the data in a clever way.
Cross-validation is a technique one can use when working with limited data, so
we decided to use this. Cross-validation divides the data into K equal folds. One
part is left out and used as a test set. The machine learning runs K-1 training
iterations, where the part used as a validation set changes in each iteration. An
example is shown in the figure below.
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Figure 2: Cross validation
When we used cross-validation, we kept the ratio between the outcomes was kept
in each fold, which is called a stratified split. That way, all folds still represent the
real data, as the ratio between outcomes is equal in the train, validation, and test
set.
3.7 Evaluation
After our model was created, we had to measure how well it was able to identify
medical deterioration, and how accurate the predictions are. In machine learning,
there exist multiple methods to evaluate a model. Before going through the different
techniques used to evaluate our model, we need to understand some general terms
for evaluating binary classification.
True Positives(TP) = Both the prediction and the true value is 1.
False Positives(FP) = The prediction is 1, while the true value is 0.
True Negatives(TN) = Both the prediction and the true value is 0.
False Negatives(FT) = The predicted value is 0, while the true value is 1.
A confusion matrix is often used to display a more visual representation of these
values and can be seen below.
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Figure 3: Example of confusion matrix
In the figure above, it visually shows that of 14 cases of class 0, a network
predicted 11 correct and 3 wrong. For case 1, the network also predicted 8 of 13
instances correct for class 1. The data shown are randomly generated to explain a
confusion matrix.
Accuracy
Accuracy is probably the evaluation method most people think about when speaking
of metrics. The formula for accuracy is:
Accuracy =
TP + TN
TP + FP + TN + FT
Using accuracy to evaluate a model is fine when there are about the same number of
each labels. As our data is highly imbalanced, accuracy would not fit for evaluating
our model. For example, if predicting if a person has diabetes or not, and the data
have 2 out of 100 persons with diabetes, the model could predict that no one has
diabetes. By making that prediction, the model achieves a 98% accuracy.
Precision and recall
Precision and recall are a method for calculating how many instances of a label a
model is able to identify and how believable a prediction is. Both precision and
recall need to be calculated for each label.
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Precision calculates that when a model gives a prediction, what are the proba-
bility the model is correct. This means, after our model gives a prediction that a
patient have a high risk for medical deterioration, we can state how strongly we can










When the model predicts outcome 0, it is a 69% chance that the model is correct.
Recall calculates the models ability to identify all relevant instances of a outcome.











With a score of 0.79 in recall, it means the model is able to identify 79% of all cases
of class 0.
ROC curve and AUC
Roc curve and AUC, also called AUROC, is often used to compare different tests
and can be used to alter the threshold between classifications. We use it to compare
both experiments in the thesis.
ROC curve or receiver operating characteristic curve is a graph where the true







These rates are plotted at different classification threshold.
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AUC, or area under the curve, measures the area below the ROC curve, as seen
in the figure below.
Figure 4: AUROC graph
It outputs a number between 0 and 1. A 0.5 score means the predictions are
random, lower than 0.5 means the predictions are worse than random. So the closer
to 1 the better. A rule of thumb for translating the AUC score into regular speech
is as followed[28][32] :
• .90-1 = excellent (A)
• .80-.90 = good (B)
• .70-.80 = fair (C)
• .60-.70 = poor (D)
• .50-.60 = fail (F)
14
4 Neural Networks
The type of machine learning model created in this thesis is called a neural net-
work(NN). The data we use is time-series based, and the main reason we chose to
use neural networks is because of a particular subtype of neural networks called re-
current neural networks, which is created for processing time-series data. A neural
network is a set of neurons, or also called nodes, separated into different layers. For
a network to make predictions, data goes through all layers, and the final layer out-
puts a prediction. Both experiments completed in the thesis are done by creating
neural networks.
A neural network starts with a input layer, which has as many neurons as there
are features in the dataset. After the input layer, there are one or more hidden
layers, which finds patterns in the data. The more hidden layers, the more complex
problems the network can solve. The last layer is called the output layer, which
outputs the prediction of the network.
Figure 5: A simple neural network
As you can see in Fig 5, each layer is built up of several neurons, which contain
a given weight. When a neuron gets input, it calculates the dot product between
the input X and the weights W.
X = [x1, x2, ..., xi]
W = [w1, w2, ..., wi]





The dot product is then sent to an activation function, which determines the output
of the neuron
4.1 Backpropagation
A neural network starts with randomly initialized weights. After initialization, the
training data is fed through the network, which is called feed-forward. The next
step for the network is to make predictions on the data. After the predictions are
made, the network uses a loss function to see how well it performs. Afterward, the
network goes backward through the layers of the network and updates the weights
with small steps to reduce the error from the loss function. Weights are updated by
a learning algorithm called gradient descent is commonly used. The goal of gradient
descent is to minimize the result of the cost function by finding a global minimum
for the function. To decide how much to alter the weight, we use the learning rate,
given as a hyper-parameter, to the model. Backpropagation is an iterative process,
which happens multiple times in the training phase of a network.
4.2 Activation functions
Given the input to a node in a NN, the activation function calculates the output
of the neuron. By using these non-linear functions, neural network is able to solve
complex problems, which would not be possible in a linear space.
Sigmoid function
Sigmoid is a activation function that ranges from 0 to 1. It is often used to predict
classes as the output can be directly translated to the probability the data is of a
given class. Often the threshold is 0.5, which a network will predict the data is class













Relu or Rectified Linear Unit is an activation function that removes negative values.
It has proven to work well for very deep neural networks.
Relu(z) = max(z, 0)
Figure 6: Activation functions
Above is three graphs that display the described activation functions.
4.3 Loss functions
A loss function is a performance metric of how well the model can make predictions
on the input data. As machine learning data and problems may vary, there exist
multiple different loss functions. The loss output from the loss function is used in
the training of a machine learning model. The higher the loss output, the worse
the model performs. In training, a model will try to optimize(minimize) the loss by
adjusting weights in the model. There exist two main categories for calculating loss,
regression, and classification.
Mean Square Error
An example of a loss function used in regression tasks. Calculates the mean error






n equals the number of samples, y is the correct value, and ŷ is the predicted value.
17
Binary Cross-Entropy
Binary cross-entropy are often used when solving a binary classification task. It
can also be used for multi-label classification problems, if the different labels is
independent of each other.




(y ∗ log(ŷi) + (1− y) ∗ log(1− ŷi))
n equals the number of samples, y is the correct value, and ŷ is the predicted value.
Categorical Cross-Entropy
Categorical cross-entropy is used for classification tasks when there are more than







y is the correct value, and ŷ is the predicted value.
These 3 are just examples, and there exist multiple different loss functions. Se-
lecting the right function will depend on the type of problem and the context. As
our data has various outcomes that are treated independently of each other, binary
cross-entropy is the loss function we chose for our models.
Choosing a learning rate
Setting the learning rate of a model mainly affects its ability to make predictions. A
too-small LR could make it very time consuming to find the global minimum. Setting
the learning rate of a model too high can cause it to overshoot the minimum, which
makes the model diverge instead of converging, never finding the minimum. Using
an adaptive learning rate is a technique where you start with one learning rate, then
alter the learning rate in the training process. Usually, it is used to start with a
higher learning rate, then decreasing it as you get closer to the minimum. As you
get closer to the minimum, you reduce the learning rate to avoid overshooting it.
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4.4 Dropout
To prevent overfitting, we used a technique called dropout. Dropout is a technique
in machine learning where the model simply ignores some parts of the data. Dropout
is implemented as a layer, which has a parameter for how much of the data should
be ignored. A NN can contain multiple dropout layers.
4.5 Embedding
The data we have contains a lot of categorical values, and have to be processed before
it is sent to a neural network. One way to do this is by usingWord2Vec or embedding,
which is a normal method when working with natural language problems. Words
are translated into vectors, and a machine learning model can train and change the
values in the vector. Cheng Guo and Felix Berkhahn [13] found that by using the
embedding technique on categorical variables, it reduced memory usage, sped up the
neural network, and, most importantly, it led to the categorical features to gain a
richer representation. The categorical variables could be mapped into vectors where
the vector values could represent properties. After we had used embedding, the id of
a patient was represented as a vector. The id could represent additional information
about the patient instead of just being an identifier for the patient.
4.6 Long Short Term Memory Networks
Our data is based on time-events, which is hard for a normal neural network to
process. One patient has multiple events, which means that previous events need to
persist in a network. A Recurrent neural network(RNN) contains loops that make
it possible for the network to persist information[30]. By persisting the data, the
network can use data from earlier events while processing data and is the reason it
performs so well on time-series data, such as in this project. LSTM is a special type
of RRN, which can persist data for a longer amount of time. To further understand
a LSTM network, we need to look at a LSTM unit. Each unit has three gates and
a cell state, as shown in the figure below.
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Figure 7: A LSTM unit
Source : http://colah.github.io/posts/2015-08-Understanding-LSTMs, used with
permission from creator, Christopher.
Forget gate:
A forget gate(1 in the figure) looks at the previous data point and makes a decision
of which parts of the previous data is relevant to keep in memory. Thus, only re-
membering the important data. The values sent out of the forget gate is between 0
and 1, where 1 means the data is important.
Input gate:
The input gate(2 in the figure) takes the hidden state(h(t-1)) and the current input
and sends it into a sigmoid function. The output will be between 0 and 1, where
1 means that this data should be updated. At the same time, the same data goes
through a tahn function, which outputs a number between -1 and 1 to help regularize
the network. In the end, the output from the sigmoid function gets by the output
from the tahn function. The tahn function help regularize the network, while the
sigmoid function decides which of the data from the tahn function is important.
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Cell state:
After the forget and input gates, the network calculates a cell state. First, the cell
state gets pointwise multiplied with the output from the forget gate, which can re-
move data if the forget gate vector is close to 0. Then the network does pointwise
addition to the input gates output data, which updates the cell state.
Output gate:
The output gate(3 in the figure) calculates the next hidden state. The output gates
take the current input and the hidden state of the previous node. The output gate
feeds the previous hidden state and the current input into a sigmoid function. At
the same time, the network takes the new calculated cell state and feeds it to a tahn
function. Lastly, the output from the tahn and sigmoid functions is multiplied to
determine what information the new hidden state should be. The new hidden state
and the new cell state is then sent to the next node or used as a prediction.
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5 Research approach
There were several phases in this project. First, we need to get approval from
Regional committees for medical and health research ethics(REC), then we need to
set up the software system to be used. We had to clean the data, and finally, then
the operation phase, where conducted the experiments and finally a post phase. We
will go through all the stages here.
5.1 Regional committees for medical and health research ethics
Since this project uses sensitive data, the project had to be approved by Regional
committees for medical and health research ethics(REC). REC is a group of com-
mittees which provides approval for medical and health research project, general
and thematic research bio-banks and dispensation from professional secrecy require-
ment for other types of research. REC consist of seven regional committees, which
consist of people of different backgrounds. The Ministry of Education appoints all
committees and serve for four years.[9] We filed our REC application on 20.06.2018
and was approved on 24.09.2018. For another similar project with a time deadline,
it is essential to start the REC process early.
The REC approval process required a final definition of all research questions
before the project started, and the thesis could not change after REC’s approval. As
the thesis had to be approved by REC beforehand, the main research questions and
purpose could not change after approval, which reduces the chance to introduce bias
in the thesis. Publication bias is reduced as the thesis will be publicized regardless
of the findings, and the thesis cant is altered to fit the findings better.
As there are strict routines when working on sensitive data, there were essential
to have a secure development environment. A laptop that could be used to do
data processing was ready on 14.11.2018. Lastly, the final computer to run machine
learning algorithms was prepared to use on 15.07.2019. The computer had one GPU,
meaning that only one machine learning process could be running simultaneously,
making it a slow process. Using multiple GPU’s would definitely make it possible
to test more machine learning techniques and hyper-parameter tuning. The time-
demanding processes of the REC application and the set up for the development
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environment led to some delays for the thesis.
5.2 Data
After the project’s approval and the setup of the development environment, it was
time to analyze and process the data. In this step, we seek to gain a deeper under-
standing of the data. You have to fill or remove rows with missing data, followed by
featured engineering. An overview of the data and the processing steps are written
in detail in section 7.
5.3 Operation
This study was empirical in nature; we applied machine learning algorithms to
the data that we cleaned, see section 5.2. The machine learning model learns from
patterns regarding the patient previous medical history, which exists in the patient’s
medical record. In this step, validation played an important role; for each training
iteration, we changed the data used to validate the model, which is described in
section 3.6. Another set was left out when training the model, which is used to
evaluate the model after training. The different evaluation methods are described in
section 3.7. Each of the experiments will be outlined, and they follow this template:
1. A description of the models’ architecture
2. An overview of hyper-parameters, batch size, loss function, and optimizer.
3. A combined overview of the results achieved in both experiments.
5.4 Post phase
One can view the overall study as a feasibility study: to find out how good machine
learning is for predicting medical deterioration in patients diagnosed with diabetes.
The evaluation methods used to make it possible to give an accurate statement
about how well the model is predicting. The thesis can also be used to show that




Bringing machine learning into the field of medicine has opened up a lot of possi-
bilities. At the same time, it is important to think about negative consequences or
difficult ethical questions regarding machine learning in medicine. Federico Cabitza,
Raffaele Rasoini, and Gian Franco Gensini wrote an article[7] going over four unin-
tended consequences of introducing machine learning into the health care system.
The four unintended consequences they list are:
1. Physicians can over-rely on automation and technical applications in their
field, which can reduce their skill in their field.
2. Relying on machine learning and automation can lead to an increased focus
on the text, images, and other data. Context and other patient information
can be hard or impossible to transcribe into data or may be missing from data
files.
3. Intrinsic Uncertainty in Medicine
4. The black box problem in machine learning.
The first two are highly relevant to this project. Diabetes is a lifestyle disease,
lifestyle data can be hard to translate into medical data, or the data is non-existing as
well. The consequence of this is that the solution created in this project should only
be used to identify patients with a high risk of experiencing medical deterioration,
with the goal of contacting them and then use medical professionals in consulting
sessions. Meaning that the skill of the professional is important, both to give advice
and to detect information about the patient, which is not transcribed in the medical
records. For the fourth consequence, the goal of this project is to find patients
with high risk for negative consequences, so they can get a doctor’s appointment to
discover why and how to prevent it.
Another important factor when discussing ethics is a bias regarding gender, race,
or religion. A study[16] was made to create a machine learning network to give a
risk analysis of which prisoners should be released from prison. The network ended
up giving black people a much higher risk of doing.
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7 Data
This chapter describes the pre-processed data, the steps completed in feature engi-
neering, and the balancing of the outcomes.
7.1 Pre-processed data structure
The data given by Haukeland contains data for around 20.000 patients. It is event-
based where each event has information about one of the following:
• a patient arrived at a hospital department
• a patient left a hospital department
• a diagnosis was assigned
• a procedure was performed
• the patient did not turn up for a hospital appointment
• the patient rescheduled a hospital appointment
• the patient tested HbA1C, urine glucose or serum glucose (includes the result
of the test)
• the patient changed their address
• the patient died
Below is a table of fake data that shows the structure of the original data, when
it was received.
Figure 8: Example of data
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A lot of the titles in the table is self-explanatory, and will not be described. The
first row, "patient_id" is a uniquely hashed identifier for each patient. "event_comments,"
explains the type of the given event, while "event_value," gives supplementary infor-
mation. If multiple events for the same patient happened with the same timestamp,
the row "order" is used to sort the events in the correct order. "test_value" con-
tains a value of an HbA1C, urine glucose or serum glucose measurement. The field
in_reference states if the test is in the standard reference area for the given test.
In the data, there were five different outcomes classified as 1, 2, 3, 4, and 10.
• outcome 1: Transpupilary laser treatment of retina, partial toe amputation
and Partial amputation of a finger
• outcome 2: Intertarsal amputation
• outcome 3: Amputation of the femur and Transmetatarsal amputation
• outcome 4: leg amputation
• outcome 10: Death.
Figure 9: Outcome Table
The table above shows the total occurrences for each outcome. It also shows how
many with a given outcome also have one of the other outcomes. It would be
reasonable to think that people with outcome 10 would also experience a large
number of other outcomes, which lead to further investigation of the data.
26
Figure 10: Outcome 10 based on age
As shown in the diagram above, most of the patients with outcome 10 is 65
years or older. This can make it harder to identify young patients with a high risk
of mortality.
7.2 Data processing
Processing the data serves two purposes. First, a dataset must be in a format that
can be sent into a neural network. Secondly, it can also improve the prediction
capabilities of the network. The first step was to fill in for missing values in the
dataset. Missing "date of birth" was filled out by copying from other events from
the same patient. Gender went through the same step as the date of birth. Missing
test value was replaced by 0, while in reference was filled with not measured. The
"in reference" field included different spelling for the same values. The data was
altered to contain one type of spelling that was used; otherwise, a neural network
would look at them differently.
Feature selection
• Event_id was removed as it is unique for all events in the data, which makes
it useless when learning a machine learning network to find patterns.
• Removed event_comments that occurred less than five times in the whole
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dataset, which removed 14513 events. These events were removed for the
same reason as the choice to remove event id from the data. Event comments
are a medical code that explains a given event.
• The last step of removing events from the data was to remove patients with
less than ten events, which removed 1207 patients, bringing it to a total of
19258 remaining patients.
After feature selection, the data would look like this:
Figure 11: Data after feature selection
The second row is removed as it contained an event that happened under five
times, while the two last rows were deleted as the patient had too few events
in total. The yellow is specifies the changes to the in_reference and test_value
columns. In the test_value, Nan is replaced by 0, while the None values in the
column in_reference are replaced by "Not measured."
Feature extraction
• Each event contained the date of birth but was replaced by age at the given
time of the event.
• Date of the event was changed from being a single field to four different; Day,
Week, Month, and Year.
After feature extraction, the data would look like this:
Figure 12: data after feature extraction
As seen in the yellow columns, birth is replaced by the age at the given time of the
event. Event_time is split into four different columns, which is; year, month, day,
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week.
Before starting to train the neural network, variables had to be classified as cat-
egorical or continuous variables. This step was completed to select which variables
should be sent through an embedding layer in the network. The following variables
were classified as categorical: department, event comment, in reference, event name,
event value, patient id, year, month, day.
7.2.1 Data balancing
Since most of the patients did not experience any of the cases, balancing had to be
done. As explained in chapter 9, mortality was the only case predicted on in this
study, meaning that only balancing for that outcome was completed. Before bal-
ancing, the training data contained 14501 patients who did not experience outcome
10 and 1132, who did, as shown below.
Figure 13: unbalanced data
Two techniques were used to counter the unbalance in the data. First, the
patients with outcome 10 were copied four times. The copied patients were given
a new unique patient id so that each copied patient is treated individually by the
model. It is optimal to have an equal ratio between the outcomes, although if a few
patients are copied too many times, a model may overfit on those cases. After this
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balancing was completed, the number of patients with outcome 10 was now 4756.
The new balance is shown in the graph below.
Figure 14: Balanced data
Lastly, a function from Keras, see chapter 8, called class_weight, was used when
training the model. The function is used to let different classes affect the loss
function differently. In our models, outcome 10 affects the loss more than not having
outcome 10.
Another technique that could have been used to avoid overfitting of the copied
patients is undersampling, which is when cases of the superior label are removed to
balance the dataset.
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8 Tools and implementation
This section gives a brief overview of the tools used in the project and the implemen-
tation of the solution. It is included in the study for others to be able to reproduce
the study using the same approach, as the code written in the study is not public
due to using sensitive data. The chapter can be skipped when reading the study.
The implementation of the experiments used in the project is written in the
programming language Python. It also uses multiple supplementary libraries such
as; Pandas, Numpy, FastAi, Scikit-learn, and Keras. The most used libraries are
explained below.
TensorFlow
Tensorflow[1] is an open-source platform for machine learning. TensorFlow was
developed by researchers from the Google Brain team within Google’s Machine In-
telligence Research organization. TensorFlow was not used directly but is used by
Keras.
Keras
Keras[8] is a high-level API for writing Neural Networks which can run on top of
TensorFlow. Keras focuses on user-friendliness, modularity, and easy extensibility.
It simplified the process of creating a neural network, which made it possible to
spend more time on data processing and the neural networks architecture and feature
engineering in this project. All models created in the study are created using Keras.
An example of how a neural network is implemented is shown in the second code
snippet below.
Scikit-learn
Scikit-learn[26] is another library to create machine learning models. The thesis
uses a small selection of functions used from the library, to avoid spending time on
implementing functions which can easily be imported from scikit-learn. We used
functions to create the confusion matrices and calculate the AUROC score, which
can be seen in section 9.
31
FastAi
FastAi is yet another library to create machine learning models. The thesis uses
one function from the library; add_datepart, which takes in a date and adds extra
columns relevant to the date.
8.1 Implementation
Most of the implemented code can be found at https://github.com/Andreass2/
medical-deterioration-of-diabetes. The structure of the git repository is split
into the following files:
Utils.py
It contains helper functions to improve the readability of the code. This file includes
functions for balancing the data, fill in missing values, and splitting the data into
multiple datasets.
CleanData.ipynb
This is where most of the data cleaning and feature engineering is completed. A lot
of the helper functions in Utils.py is used here.
PredictOutcome10_base.ipynb
This is the file where the first experiment is implemented. The file contains the im-
plementation of the neural network used, and some structural changes to the data
to be able to feed it to the network.
PredictOutcome10_with_time.ipynb
This is a similar file to PredictOutcome10_base.ipynb, but contains the implemen-
tation of experiment 2. This is also the file that removes events in a specified time
before a mortality event.
A standard LSTM network requires each data-point to have the same number of
rows. In our data, each patient had a different number of events. This was the
most complex problem during the implementation of the experiments, and we had
multiple discussions on how to solve this problem.
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We created a solution using python’s "None" value, which can be used to rep-
resent variable length. The input size for categorical values had to be (1, None 1),
and the input size for the continuous variables had to be (1, None, 3). The None
value represents the length of the medical records for a given patient. The last value
represents the number of columns given to the layer. As all categorical variables
were sent into a different layer, the input layer was fed one column at the time.
There were three different continuous values, meaning the input layer was fed three
columns.
To feed the data into the network during training, we had to use fit_generator
from Keras, with a function we implemented to feed the data in the correct structure
to the network. Below you can see the code for the training data generator we
implemented.
def t ra in_generator ( indexes = [ ] ) :
#step 1
i f ( len ( indexes ) == 0 ) :
indexes = [ i for i in range ( len ( X_train )−1)]
s h u f f l e ( indexes )
i = 0
while True :
i f ( i >= len ( indexes ) ) :
print ( " r e s e t ␣ t r a i n ␣ index " )
i = 0
df = X_train [ indexes [ i ] ]
l ength = len ( df )
inputs = [ ]
#step 2
for cat in cat_names :
inputs . append (np . array ( df [ cat ] ) . reshape (1 , length , 1 ) )
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#step 3
inputs . append (np . array (np . array (
df [ [ ’ age ’ , ’ gender ’ , ’ t e s t_value ’ ] ] )
. reshape (1 , length , 3 ) ) )
i = i+1
#step 4
y i e l d inputs , y_train [ indexes [ i −1 ] ] [ ’ 10 ’ ] . va lue s
This function required four step.
1. The first thing that has to be done is to find the correct patient.
2. For each categorical value, the data is reshaped into (1, number of events, 1)
3. Then we add the continuous variables in the shape of 1, number of events,
number of variables)
4. send the data to the network.
Below is simplified code(full code in GitHub) for the implementation of the
second experiment.
inputs = [ ]
l a y e r s = [ ]
# Step 1
for cat in cat_names :
i = Input ( batch_shape=(1 ,None , 1 ) , name=cat )
e = Embedding ( vocab , embedding_size , input_shape=(1 ,None , 1 ) ) ( i )
r = Reshape ((−1 , embedding_size ) ) ( e )
inputs . append ( i )
l a y e r s . append ( r )
#step 2
i = Input ( batch_shape=(1 ,None , 3 , ) )
l a y e r s . append ( i )
34
# Step 3
merged = Concatenate ( ) ( l a y e r s )
norm = BatchNormalizat ion ( ) ( merged )
f = LSTM( hidden_size , dropout =0.5 , r e cu r r en t_r e gu l a r i z e r=’ l 2 ’ ,
return_sequences=True , s t a t e f u l=False ,
use_bias=True ) ( norm)
x = LSTM( hidden_size , dropout =0.5 , s t a t e f u l=False ,
r e cu r r en t_r e gu l a r i z e r=’ l 2 ’ ,
use_bias=True ) ( f )
out = Dense (1 , a c t i v a t i o n=’ s igmoid ’ ) ( x )
inputs . append ( i )
# Step 4
model = Model ( inputs=inputs , outputs=out )
As seen in the code above, this snippet can also be explained stepwise.
1. The first step is to create the input, embedding, and a reshape layer for each
categorical value.
2. Creates the input layer for the continuous variables.
3. The input layers are concatenated so that a single layer can process all data
at the same time. This is also the step where the LSTM layers are created.
4. Creates the model.
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9 Experiments
This section goes through the two different approaches used in the project to pre-
dict the data set. It was decided to use multiple methods to compare different
approaches. As the goal of the experiments varies, the data in each experiment also
varies. Experiment 2 excludes 22 patients who were included in experiment 1.
Both experiences use the same neural network architecture, as shown in the
figure below.
Figure 15: The neural network architecture
The network contains one input layer for each of the categorical values, which
makes it possible to adjust the size of the embedding matrix individually. It is also
a single input layer for all continuous variables, which includes age, gender, and
test_value. After the embedding layers, the embedding matrix is sent to a reshape
layer to represent the embedded data in the same structure as the continuous data.
The concatenate layer combines the data from all layers. The batch normalization
layer standardizes the input. Two LSTM layers are used, which both have the size
of 40 neurons and the same parameters, which are:
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• The first LSTM layer has return_sequences set to true, which is needed to
keep the data in a format the next LSTM layer can process.
• Dropout is set to 0.5
• Recurrent_regularizer is set to use l2
• use_bias is set to True
The last layer is a Dense layer, which uses sigmoid as an activation function. The
dense layer outputs a value between 0 and 1, which is the prediction.
9.1 Experiment 1
The first experiment’s goal is to give a proof of concept that the dataset contains
detailed enough data for predictions to give value. Mortality is the only outcome
included, as it is the most common negative outcome. The network predicts a binary
outcome of 0 (no risk of mortality) and 1 (risk of mortality).
Parameters
• Learning rate: 1e-4
• Learning rate decay: 1e-5
• Optimizer: Stochastic gradient descent, 0.8 momentum, nesterov set to true
• Loss function: binary crossentropy
• batch size: 512
• class weight: 0:1, 1:1.2
9.2 Experiment 2
This experiment extends Experiment 1. Like the previous experiment, the model
only predicts mortality but excludes the last four weeks before mortality happened.
The goal of this approach is to represent the problem more realistically. The network
should be able to predict the risk of mortality as early as possible. If the network
is only able to predict if a patient dies the same day, it does not add value. This
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experiment excluded patients who only had events in the four weeks before mortality
happened.
Parameters
• Learning rate: 1e-4
• Learning rate decay: 1e-5
• Optimizer: Stochastic gradient descent, 0.8 momentum, nesterov set to true
• Loss function: binary crossentropy
• batch size: 512
• class weight: 0:1, 1:1.2
Results
After implementation, the neural networks had to make predictions on data that
had not been included in training or validation. To find the result, we use multiple
metrics, as explained in section 3.7. We start with the confusion matrices for both
experiments.
Figure 16: Confusion matrices
Above, it is shown that the model from experiment 1 predicted 2800 correctly
and 825 wrong for class 0. While for class 1, it predicted 178 correctly and 48 wrong.
The second model from experiment 2 predicted 2903 correctly and 722 wrong for
class 0. While for class 1, it predicted 100 successfully and 104 wrong. The first
experiment has more accurate predictions than the second.
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Further, we need to look at precision and recall, which can tell how many in-
stances of high-risk patients the models can identify and how reliable a given pre-
diction is.
Precision 0 Recall 0 Precision 1 Recall 1
Experiment 1 0.98 0.77 0.18 0.79
Experiment 2 0.97 0.80 0.12 0.49
Experiment 1
Out of all cases of class 0, the model can identify 77% of them. When the model
predicts outcome 0, it is a 98% chance that the model is correct. As for class
1, the model can identify 79% of all cases. When the model predicts outcome 1,
it is a 18% chance that the prediction is correct. The precision and recall for class
0 is higher than for class 1, this is expected as we have much more data about class 0.
Experiment 2
Out of all cases of class 0, the model can identify 80% of all cases. When the model
predicts outcome 0, it is a 97% chance that the model is correct. As for class 1,
the model can identify 49% of all cases. When the model predicts outcome 1, it is
a 12% chance that the prediction is correct. Again predictions on class 0 is more
accurate than class 1.
The last metric we used is AUROC.
Figure 17: AUROC graphs
The first model got an auc score of 0.85, while the second model got a score of
0.76.
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As there was an imbalance between age in patients with the mortality outcome,
we decided to check how well the models perform for patients over and under 65
years.
Under 65 Over 65
Experiment 1 35/39 143/187
Experiment 2 15/37 85/167
’ For patients over the age of 65, model 1 had an accuracy of 76.5%, while model 2
had an accuracy of 50.9% When we look at patients under the age of 65. Model 1
predicted correct for 89.7% of those patients, while model 2 predicted correctly on
40.5%.
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10 Interpretation of results
In this chapter, we take a closer look at the results. Patients without outcome 10
will be referred to as class 0. Patients with outcome 10 will be referred to as class
1. The first model achieved a better result, which was expected. We removed the
last four weeks from all patients with class 1 in the second experiment, which means
there is less detailed data for each patient. The main focus will be on the second
experiment, as it predicts the risk of mortality at an earlier stage.
Recall would be the most crucial metric when interpreting the results. It explic-
itly tells how many instances of negative outcomes the networks can identify. The
first experiment was able to identify 79% of all mortality cases, while the final result
for experiment 2 is that the network was able to identify 49%.
Precision is lower than recall in both experiments. When the models predict a
high-risk patient, model 1 has an 18% chance of being correct, while model 2 has
a 12% chance of being right. This means Haukeland could potentially use time on
the wrong patients.
The AUROC scores for both models are well above 0.5, meaning both models
predict much more accurately than random. If we use the rule of thumb from section
3.7, the first model can be classified as a good result, while the second model can
be classified as fair results.
The results can be used to answer research question 1 directly; "how well can medical
record data be used in machine learning to predict medical deterioration of patients
diagnosed with diabetes?". Given that the results are written in the percentage
of how many negative outcomes the network can identify and how many high-risk
predictions are believable predictions, it gives a clear answer. As experiment 1 can
identify 79% of high-risk patients, it is clear machine learning can be a useful tech-
nique when working on medical records. In experiment 2, the network achieved a
lower score but still manages to identify almost half of the high-risk patients.
The second research question: "By removing the latest events for a patient,
how early can the risk of medical deterioration by identified?" can be answered by
comparing the results from experiments 1 and 2. As expected, the result from the
first experiment performs more accurately than the result of the second experiment.
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By removing the last four months before mortality, recall is reduced from 79% to
49%, while precision is reduced from 18% to 12%. The decrease in the results from
experiment 1 to experiment 2 is expected. The most critical events for predicting
the risk for mortality will be closer in time to the mortality event. The AUROC
score classifies the model’s results as fair. This means that the network is still able
to detect patterns at an earlier stage, at the cost of precision and recall.
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11 Threat to validity
Validity explains whether or not a study is trustworthy and meaningful. When
speaking of the threat to validity in research, there exist mainly two subcategories,
internal and external. Internal validity concerns the structure of a study, how well
it is conducted. It is often linked to how confident one can be with the findings
when doing research. There are multiple threats to the internal validity in this
thesis, for example, the assumptions made about the medical records. As there may
exist outdated procedures in the dataset, it decreases the trustworthiness of the
correlation between procedures and the outcomes for a patient. Measures were taken
to improve internal validity. When splitting the dataset into a train, validation, and
test set, patients were randomly selected for which set they should be in, although
the initial ratio of the number of outcomes was kept in all sets.
External validity is about how well the findings or outcome of a study can be
applied to other cases; in other words, how well the outcome can generalize. Gener-
alization is also a big topic in machine learning, as the goal of most machine learning
models is to be able to make predictions on new unseen data. Threats to the external
validity in this thesis may be:
• Selection bias: As mentioned in the introduction, there were over 200 000 reg-
istered patients with diabetes in Norway in 2016. The dataset in this project
has around 20 000 patients. This means that it cant be certain that all de-
mographic groups are included in this study. This can also affect internal
validity.
• Outliers and noise: If the dataset contains a lot of noise or outliers, the neural
network may "find" patterns in those, which will probably make the network
generalize less. Common methods in machine learning are to remove outliers
from the data and to use dropout, which makes the network generalize better.
• A patient may have other diagnoses and receive treatments from the healthcare
system, making the network finding rare patterns that may limit generaliza-
tion.
Multiple steps to improve external validity can be taken. Replicating the study with
different data samples, and then using meta-analysis can improve both internal and
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external validity. The thesis is written in a way that another study should be able
to use the same approach on different data. In the following chapter, exclusion/in-
clusion criteria are clearly defined, so that others can process the data in the same
way this thesis does. Most of the code is available, making it possible to replicate
the project without problems. To see if the network is able to generalize and pre-
dict new unseen data, a test set of patients was excluded from training the neural
network. The findings of the thesis are based on how well the network is able to
make predictions on the test set, which directly tests the external validity.
We had to make multiple assumptions in this project due to the data and time
limitations on the project. These assumptions will increase the threat of validity.
The first assumption is that there are no changes in procedures and routines over
time. For example, data from 1970 is processed the same way as data from 2015.
The next assumption is that no other data is needed to predict medical deterioration.
The patient’s lifestyle is essential regarding medical deterioration for diabetes, but
the data given from Haukeland does not contain such data, so it is assumed that this
kind of data can be disregarded. In the thesis, we assume that consultant sessions
with a patient will be able to prevent medical deterioration, but to be able to state
this, testing has to be completed. It is relevant to know that these three assumptions
are not realistic for the real world but only made for the project to be feasible. The
three different types of diabetes are not processed differently, so it is assumed that
to know which type of diabetes the patient has is enough.
The thesis uses real data in a structure used by the healthcare system today.
This is exciting, as there was much doubt regarding the approval from REC. When
creating fake data, the generated data may not represent real data in the correct
way. In fake data, ratios between gender, age, labels, and event codes could have
been wrong, making it easier or harder for a network to make predictions on the
fake data. It would be easier to create data that would fit the thesis, introducing




MIMIC-III is an extensive database that includes data for 38,597 patients admitted
to critical care units in USA[17]. The data is collected between 2001 and 2012 and
has been completely anonymized. The data has a different structure as the data we
received from Haukeland. If we started working with the MIMIC-III dataset, we
would have to redo all data processing when working with our data. Instead, I have
worked with this dataset in another project to prepare for this thesis, which can be
found on https://github.com/Andreass2/HospitalMortalityRate.
As the data is open, it makes it possible to reproduce and improve studies com-
pleted on the dataset.
Predicting Mortality in Diabetic ICU Patients Using Machine
Learning and Severity Indices
"Predicting Mortality in Diabetic ICU Patients Using Machine Learning and Sever-
ity Indices"[3] is a study where they used the MIMIC-III database to predict mor-
tality for diabetic patients in the ICU. The study achieved an AUROC score of 0.787
by combining HbA1c, mean glucose during the stay, diagnoses upon admission, age,
and type of admission. This study predicts mortality at a given hospital stay, while
our goal is to predict as early as possible. The study is still important to us, as
it states the importance of the data variables used when predicting mortality for
diabetic patients.
Deep learning algorithm predicts diabetic retinopathy progres-
sion in individual patients
"Deep learning algorithm predicts diabetic retinopathy progression in individual
patients,"[4] is a study in which they created a neural network to make predic-
tions on diabetic retinopathy progression for individual patients. There are multiple
differences between this study and ours;
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• Treatment of retina is included in our data as outcome 1, although we would
also be able to predict different outcomes at the same time.
• This study uses eye-screenings to make predictions, while we want to see if
similar predictions can be completed while using medical records.
Predicting Diabetes Mellitus With Machine Learning Tech-
niques
"Predicting Diabetes Mellitus With Machine Learning Techniques"[33], is a study
that predicted if a patient had diabetes. They used a machine learning model called
"random forest" and achieved an accuracy of 0.8084. They found that fasting blood
sugar, age, and weight is important attributes when predicting diabetes. In the
study, they state: "According to consulting relevant information, we know there are
three indicators to determine the diabetes mellitus, which are fasting blood glucose,
random blood glucose, and blood glucose tolerance."(Zou et al. 2015). This study
shows the importance of blood glucose levels has in diabetes.
Type 2 diabetes risk forecasting from EMR data using machine
learning
Mani et al. [19] used different machine learning techniques to forecast the risk of a
patient developing diabetes. Their study combined demographical, clinical, and lab
data in predictions and manage to achieve an AUROC score of 0.8 when assessing
the risk of developing diabetes type 2 365 days before the diagnosis was given. The
data they used had a significant focus on lab values and less on medical records.
Almost all of their patients had measurements of glucose, which is highly linked to
diabetes. The data available in our study includes three different test values and a
lot of events and patients that did not have measurements.
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Haukeland University Hospital
Haukeland University Hospital, in collaboration with the University of Bergen, has
established Mohn Medical Imaging and Visualization Centre (MMIV), which has
multiple publications where machine learning is included. Most of their work is
about visualizing and processing medical images, and a complete list of their pub-
lications can be found at https://mmiv.no/publications/ Our thesis is the first
machine learning study using real medical records at Haukeland.
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13 Discussion
This has been the first collaboration between Haukeland, Western Norway University
of Applied Sciences, and the University of Bergen while working on sensitive data.
We learned the importance of an early start regarding applying to REC to approve
the project. It has the possibility to add significant delays to a similar project. While
waiting for approval from REC, we would recommend setting up the development
environment. The last recommendation would be to have multiple GPU’s as it
would speed up the practical part of the thesis significantly. We could have run
several instances of training at the same time, meaning we could have tested a lot
more techniques and hyper-parameters for the models. If we had multiple GPUs,
it would have made it possible to work on experiments 1, 2, and 3 at the same
time, meaning experiment 3 would have been included in the study. The plan for
experiment 3 is explained in 15.2. As our predictions only include mortality, we
cannot make statements about medical deterioration, but only in predicting the risk
of mortality.
In discussion with Haukeland, we agreed that the most crucial part of the thesis
was to be able to identify the high-risk patients, which is shown as the recall score.
We also decided that the misclassification of low-risk patients is accepted, which is
the reason we got a lower precision score. In the early discussions of the thesis, we
discussed a solution for preventing Haukeland to spend, which will be explained in
section 15.1.
The results could be improved if more data could be gathered, which could be
done in multiple ways. The medical records do not include data from the patient’s
general practitioner, which could include measurements of blood glucose levels in
the blood, depression, and more. Further, there exist devices that continuously
measure a person’s blood glucose levels. If that data could have been collected and
included in the thesis, by also using this data, we could collect more data regarding
patients. This would be part of the standardization of data. There is much data that
does not exist in the medical records, which could be used to better predict medical
deterioration, such as lifestyle, diet, or psychological information. For example, a
patient with depression has a 37% increased risk of developing diabetes[18]. Much
information that could improve prediction methods of patients is stored, but in
48
different systems. By having a universal standardization of data stored on different
systems, one could create an API that has access to data from multiple systems.
Then an application can get access to data from numerous sources with the same
form.
Fast Healthcare Interoperability Resources(FHIR) is a standardization for med-
ical data, which is fully integrated with mobile applications, cloud applications, and
EHR-based data sharing and server communication in large institutional healthcare
providers[15]. FHIR is collaborating with multiple of Norway’s healthcare districts,
which could mean that standardization for medical data is on the way.
Having shared standardized data can make it easier for medical specialists and
IT-applications to get all the data it needs, in the same format. It can increase
the quality and readability of the data, and make it easier to co-operate between
different systems. By using the same standard, it would also decrease the amount
of data processing needed to use machine learning.
The application to REC forced us to define the research questions before the study.
This gives the possibility to check that the research questions are not changed after-
ward to fit the data, or research questions are added or removed. This is different
from the practice in software engineering, in general, today since one does not need
to provide any material such as research questions before the study. I discussed
this issue with my supervisor, and he said that some communities, such as the ES-
EM/ISERN community, have discussed introducing the need of having pre-studies
where the research questions will be stated before the real study will be done.
Another critical issue is open data, something that can benefit research a lot. This
is discussed in many areas, and we can see more and more open data. Sometimes,
companies keep data for themselves for business reasons. In our case, data is pro-
tected because of the privacy of people. However, it would be good to find a way to
anonymous the data. However, this might not be very easy if only a few within a
country have the same illness, such as Galactosemia, in which around 30 people in
Norway is diagnosed with with[12].
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Haukeland is in possession of eye screenings for patients with diabetes, which we do
not currently have permission to use. A possibility would be to use this study as a
guide to training another neural network to predict diabetic retinopathy using eye
screenings. That network could be combined with our network to output a single
prediction of the risk regarding diabetic retinopathy progression, which could be
more accurate than any of the single networks.
After improving the accuracy of the model, it could be possible to create a new
neural network using reinforcement learning. It could add new events into the data,
then make predictions to see the new risk for the patient. If the new risk is lower, the
agent receives a reward, or if the risk is higher, the agent will receive a punishment.
That way, the network will be able to give recommendations of events and actions
which could decrease the risk of medical deterioration.
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14 Conclusion
We have shown that machine learning can be used to predict mortality for patients
using medical records. The study required multiple stages of data-cleaning, filling in
missing values, feature engineering, and balancing the data based on the outcome.
Two experiments were conducted. In the first experiment, a network was created
that was able to identify 79% of high-risk patients. In experiment 2, the network
achieved a lower score but still manages to identify almost half of the high-risk
patients. The precision score was lower than recall, but we agreed beforehand that
the most crucial metric would be the recall metric.
There exist multiple ways to collect more data, which could make our predic-
tions even more accurate. If the standardization of FHIR is completed, which is a
standardization for collecting medical data, much more data will be available for
replicating this work with more data. We strongly believe that with more data,
medical deterioration of diabetes patients may be predictable at an earlier stage,
avoid many amputations, eye operation, or even death.
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15 Further work
Here we will explain how further work can improve our current implementations and
how to add a new experiment.
15.1 Improving the completed experiments
The results achieved in the study is not accurate enough to implement the solution
at the hospital. More data analysis and feature engineering are needed to improve
the results. Some recommendations would be:
• The patients excluded in experiment 2, should be excluded in experiment 1 as
well, which will lead to a better comparison between the models.
• Gender should be processed as a categorical variable by the neural network.
• More stratified splitting in the train, validation, and test set. When splitting
the dataset into three different sets, the ratio between outcomes, gender, and
age should be as equal as possible in each set.
• When balancing the dataset, it should also balance age and gender, not only
be focused on outcomes.
• Implement Grid Search to improve the hyper-parameters of the model further.
The training of the model took around 5 hours, so grid search would be time
demanding and was down-prioritized in the study.
• Experiment 2 should be tested by removing different lengths of time.
Further, neural networks are data-dependent. If more data could be gathered
and used to train the networks, it would most likely be able to affect the results sig-
nificantly. The data used in the project contained data about 20.000 patients, while
there are 206.795 registered medical patients with diabetes in Norway. Potentially,
data from these patients could be included, enlarging the size of the data by 1000%.
Also mentioned earlier in this thesis is to implement standardization of data used
across hospitals and healthcare services. By utilizing a standardization, it would be
easier to not only gather data from more patients but also get more detailed data
about each patient.
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If Haukeland implements this solution into their daily routines, a complete
pipeline has to be created. The pipeline will select patients and make predictions
on them. Then the high-risk patients will run through a system that checks if the
patients are already in dialog with Haukeland or other healthcare services. This will
reduce the resources used on the wrong patients.
15.2 Finish the last experiment
The original goal of our research was to give predictions on all outcomes, not only
mortality. However, since it was hard to obtain accurate predictions due to lack of
data, we focus in this work on mortality since its the most common outcome, and
the idea was to show that machine learning can be used. Here we will discuss how
this can be potentially solved if the work will be continued.
First of all, the dataset has seven occurrences of outcome 2, which is too few for
a machine learning network to be able to give generalized predictions. Outcome 2
should be left out, and the model should predict the outcomes 1, 3, 4, and 10.
Before training a new model, more data processing has to be completed. A
patient can have multiple outcomes, which can be transferred into multiple instances.
The timelines below display a patient’s original data(timeline1) and replaces it with
three new data instances(timeline 2, 3, and 5), where each can be used to predict
different outcomes.
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Figure 18: Splitting a patient into multiple instances
Timeline 1 in the graph above represents a timeline for a patient in the dataset.
The patient has three different outcomes, which means we can split the data into
three "different" patients. Timeline 2 contains events up until the event the patient
experiences outcome 1, which can be used to predict that outcome. This process
should be repeated for each outcome for each patient.
If a patient experiences the same outcome multiple times, it can be used to
generate more data, as shown in the graph below.
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Figure 19: Creating more data from one patient
By doing these two steps, more data is generated, which can improve the result
of a neural network. Another benefit is that the newly generated data only contains
patients with a negative outcome, helping to balance the dataset.
The last step will be to either create a neural network able to predict all
outcomes with multi-labeling the outcomes or create one neural network for each
outcome, then combining the results afterward.
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